Table 4 Clinical and pathological features of 8 MEN2A patients with pheochromocytoma
Patient | Gender | RETmutation | Age at diagnosis PHEO | Temporal relation of PHEO to MTC | NE/E/DA (ng/L) | Tumor (size, cm) | Operative procedure | Follow-up |
|---|---|---|---|---|---|---|---|---|
F1-II4 | F | C634F | 26 | Preceding | 246.0/36.3/61.5 | L, 3.3 | Left OPE | 163 |
F2-II1 | M | C634Y | 35 | Concomitant | 399.0/48.2/43.0 | R, 2.5 | Right OPE | 74 |
F3-III7 | F | C634Y | 36 | Preceding | 827.5/106.0/88.5 | R, 4.0 | Right OPE | 71 |
F4-II3 | M | C634Y | 47 | Succeeding | 657.0/144.2/40.0 | L, 2.3 | Left LPE | 8 |
F5-II1 | M | C634R | 34 | Succeeding | 1305.0/1270.3/243.6 | L, 10 ; R, 3.5 | heterochronous bilateral OPE | 252 |
F5-II7 | M | C634R | 47 | Succeeding | 667.7/92.5/78.3 | R, 2.9 | Right LPE | 12 |
F6-III2 | M | C634R | 21 | Concomitant | 69.9/12.6/10.2 | L, 3.5 | Left LPE | 24 |
F7-II2 | F | C618R | 40 | Succeeding | 681.2/89.4/67.0 | L, 2.9 | Left LPE | 102 |